The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 31, 2017

Filed:

Feb. 13, 2015
Applicant:

Tokyo Metropolitan Institute of Medical Science, Tokyo, JP;

Inventors:

Noriyuki Matsuda, Tokyo, JP;

Fumika Koyano, Tokyo, JP;

Kei Okatsu, Tokyo, JP;

Etsu Go, Tokyo, JP;

Mayumi Kimura, Tokyo, JP;

Yasushi Saeki, Tokyo, JP;

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
C07K 16/18 (2006.01); G01N 33/68 (2006.01); C07K 14/47 (2006.01); C12Q 1/48 (2006.01); G01N 33/50 (2006.01); A61K 38/00 (2006.01);
U.S. Cl.
CPC ...
G01N 33/6896 (2013.01); C07K 14/47 (2013.01); C07K 16/18 (2013.01); C12Q 1/485 (2013.01); C12Y 207/11001 (2013.01); G01N 33/5079 (2013.01); A61K 38/00 (2013.01); G01N 2333/47 (2013.01); G01N 2333/912 (2013.01); G01N 2333/91215 (2013.01); G01N 2440/14 (2013.01); G01N 2500/00 (2013.01); G01N 2500/20 (2013.01); G01N 2800/2835 (2013.01);
Abstract

A antibody has as a target molecule a ubiquitin protein comprising a phosphorylated serine residue at position 65. In addition, a method is provided for specifically detecting Parkinson's disease at an early stage, in which a target molecule is a ubiquitin protein comprising a phosphorylated serine residue at position 65, a pharmaceutical composition for definitively treating or preventing Parkinson's disease, and a method for screening for the pharmaceutical composition.


Find Patent Forward Citations

Loading…